203-578-4 | Sigma-Aldrich

XP725 Antibody Number-Lot Number 071M4826

547 548 569 570 571 572 6.6 501 502 503 504 525 526 527 528 549 550 551 552 573 574 575 576 7.1 577 578 579 580 601 602 603 604 625 626 627 628 649 650 651 652 7.2 581 582

The Active Siteﾙ Volume 4, Number 1

640. µg of platelet protein pleckstrin 2 5 10 20 kDa 203 90 51 34 28 µg of platelet protein pleckstrin 2 5 10 kDa 203 90 51 34 28 [email protected] The

XP725 Antibody List Lot 089K4791

I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP

XP725 Antibody List Lot 129K4831

I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP

XP725 Antibody List Lot 129K4830

I9783 3840 KPNA4 M NP_002259.1 y y y 722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

Kinase, p110a H WR IP Pur Rb IgG 200 µg 07-658 Anti-PI4-Kinase b H M R IP WB IC Pur Rb IgG 200 µg 06-578 siRNA PI3 Kinase p85a siRNA/siAb Assay Kit H WB RNAi 1 kit

XP725 Antibody List

1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1

XP725 Antibody List 013M4793

1475 CSTA NP_005204.1 M y n/d n/d 202 Cytohesin-1 C8979 9267 PSCD1 NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1

Cytoskeletal Signaling Antibodies, Reagents and Kits

Kinase, p110α H WR IP Pur Rb IgG 200 µg 07-658 Anti-PI4-Kinase β H M R IP WB IC Pur Rb IgG 200 µg 06-578 siRNA PI3 Kinase p85a siRNA/siAb Assay Kit H WB RNAi 1 kit

List of Antibodies

C5351 P y n/d n/d 201 Cystatin A C3095 M y n/d n/d 202 Cytohesin-1 C8979 M y n/d n/d 203 Cytokeratin peptide 4 C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide

Halal Certificate

W342807 A97903 HC-22SIT630 577. ETHYL 3-HYDROXYBUTYRATE, NATURAL W342815 C20194 HC-22SIXH54 578. ETHYL 3-HYDROXYHEXANOATE 98%, FG W354503 B70042 HC-22SIE554 579. ETHYL 3-METHYL-2-OXOPENTANOATE

Halal Certificate

W342807 A97903 HC-24SI3Z32 577. ETHYL 3-HYDROXYBUTYRATE, NATURAL W342815 C20194 HC-24SID256 578. ETHYL 3-HYDROXYHEXANOATE 98%, FG W354503 B70042 HC-24SIWC56 579. ETHYL 3-METHYL-2-OXOPENTANOATE

XP725 Worksheet for Lot Number 071M4826

C0992 576 3 4 6 8 Anti CY3/5 C0992 577 4 1 1 1 G9a Methyltransferase G6919 578 4 1 1 2 G9a Methyltransferase G6919 579 4 1 1 3 Glutamic Acid Decarboxylase 65 G4913 580 4 1 1 4 Glutamic Acid Decarboxylase

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

cell lymphoma using [68Ga]Pentixafor: comparison with [18F]FDG-PET. Theranostics. 2021; 11(2): 567–578 (selection) 85 • Moriiwa et al.: Optimization of Analytical Procedure for In-hospital

Acta Interactive Archive Vol 51

Alizadeh, S. ChemElectroChem 2014, 1, 455. (23) Kishioka, S.; Yamada, A. J. Electroanal. Chem. 2005, 578, 71. (24) Ciriminna, R.; Palmisano, G.; Pagliaro, M. ChemCatChem 2015, 7, 552. (25) Attour